Li-Ming Zhou - Publications

Affiliations: 
Glycopep Chemicals, Inc. 
Area:
cancer, photodynamic therapy, formulation

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Jimenez EC, Donevan S, Walker C, Zhou LM, Nielsen J, Cruz LJ, Armstrong H, White HS, Olivera BM. Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Research. 51: 73-80. PMID 12350383 DOI: 10.1016/S0920-1211(02)00101-8  0.332
1997 Laszlo O, Bokonyi G, Szendrei GI, Varga I, Vasko M, Zhou LM, Skolnick P, Maccecchini ML. The flexible termini of conantokin G define its interactions with NMDA receptors International Journal of Peptide Research and Therapeutics. 4: 85-93. DOI: 10.1007/Bf02443519  0.34
1995 Gu ZQ, Hesson DP, Pelletier JC, Maccecchini ML, Zhou LM, Skolnick P. Synthesis, resolution, and biological evaluation of the four stereoisomers of 4-methylglutamic acid: selective probes of kainate receptors. Journal of Medicinal Chemistry. 38: 2518-20. PMID 7629789 DOI: 10.1021/Jm00014A002  0.335
Show low-probability matches.